ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment

This study has been terminated.
Sponsor:
Information provided by:
elbion AG
ClinicalTrials.gov Identifier:
NCT00322803
First received: May 5, 2006
Last updated: September 27, 2006
Last verified: September 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: October 2006
  Estimated Primary Completion Date: No date given